Mice homozygous for the
T he leptin-leptin receptor axis is an important regulator of feeding behavior, energy expenditure, body composition, and glucose homeostasis. Deficiencies of leptin (Lep ob/ob mice) or the leptin receptor (Lepr db/db mice, Lepr fa/fa rats) produce obesity in both humans and rodents due to hyperphagia, decreased energy expenditure, and preferential partitioning of calories into adipose tissue triglycerides (1) . Leptin is expressed in and secreted predominantly by adipocytes (2) , and it circulates at a concentration that is proportional to fat mass in both humans and rodents (3) . Changes in fat mass produce changes in plasma leptin concentrations, suggesting that circulating leptin provides a humoral signal of the mass of adipocyte energy stores (3) . Leptin may serve primarily to mediate a response to caloric deprivation and attendant loss of fat mass (4) . A starvation response is evidenced by acute downregulation of leptin expression after food deprivation and upregulation with refeeding (5) . Consistent with this role, repetitive administration of leptin to hypoleptinemic, starved mice attenuates many of the neuroendocrine changes associated with starvation (6) .
Animals with a null mutation in Lep (Lep ob/ob mice) are obese, hyperphagic, cold intolerant, insulin resistant (and frequently glucose intolerant), have an abnormally regulated hypothalamic-pituitary-adrenal axis, and are infertile (1) . Peripheral administration of recombinant leptin to ob/ob mice completely reverses the obesity by decreasing food intake and increasing energy expenditure (7) . Additionally, peripheral leptin treatment in ob/ob mice restores glucose tolerance, cold tolerance, and fertility (7, 8) . The effects of leptin on feeding behavior, energy balance, and glucose homeostasis appear to be centrally mediated, as these actions of peripherally administered leptin can be produced with intracerebroventricular injections at doses too low to affect circulating leptin concentrations (1-3 µg) (9) . Although central leptin administration appears sufficient to reverse the obesity/diabetes phenotype in ob/ob mice, several groups have reported effects of leptin in isolated peripheral tissues in vitro (e.g., pancreas [10] , muscle [11] , liver [12] , and adipose tissue [13] ). The relevance of these actions of leptin outside of the nervous system to the normal in vivo physiology of energy and glucose homeostasis are currently unclear.
The leptin receptor protein (LEPR) is a member of the class I cytokine receptor superfamily that activates the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway (14, 15) . Multiple splice variants of Lepr mRNA have been identified, each encoding an identical ligand binding domain, but differing by virtue of the presence or absence of a transmembrane domain or a complete cytosolic domain (14, 16) . Of the four "short" splice variants (LEPR-A, C, D, and E) identified, the LEPR-A isoform is the quantitatively dominant molecular species and is expressed in all tissues examined (17) . All of the LEPR isoforms that possess a cytosolic domain (A, B, C, and D) also contain the same JAK binding motif encoded in coding exon 17. However, only the LEPR-B isoform contains a Box 3 motif for STAT activation in its terminal cytosolic domain (14, 16, 18) . The LEPR-B isoform is expressed ubiquitously, but at levels much lower than the A isoform. An exception to this is the hypothalamus, where LEPR-B constitutes up to 35% of Lepr transcripts (17, 19) .
Consistent with its homology to the cytokine receptor family, LEPR-B is capable of dimerizing and activating STAT3 and STAT5 proteins in heterologous systems (19, 20) Thus, the LEPR-B isoform is proposed to be the physiologically relevant signaling isoform in the regulation of energy balance. Consistent with this inference, db/db mice, which lack only functional LEPR-B, develop an obesity/diabetes syndrome apparently identical to ob/ob mice and are unresponsive to peripheral or central leptin administration (9) . Furthermore, mice and rats possessing allelic mutations in the Lepr gene that affect all LEPR isoforms (db 3J [21] , db Pas [22] , db NCSU [23] , fa [24] , and fa-f [25] ) exhibit the db/db obesity/diabetes phenotype. Studies in vitro have revealed LEPR-A signaling activities (e.g., immediate-early genes [26] ) but the physiological relevance of this pathway to in vivo energy and glucose homeostasis is not clear.
As an initial step toward analyzing the function(s) of leptin receptor isoforms in vivo, we have created mice bearing a transgene expressing the B isoform of the leptin receptor under the control of the neuron-specific enolase (NSE) promoter (27) . We find that the expression of this transgene (NSE-Rb) in db 3J /db 3J mice, otherwise null for all leptin receptor isoforms, partially rescues the obesity/diabetes and infertility phenotypes, while correcting the cold intolerance of these mutants. Quantitative analysis of the neuropeptides expressed by three hypothalamic neuronal populations indicates that the NSE-Rb transgene affects the expression of proopiomelanocortin (POMC), neuropeptide Y (NPY), and agouti gene-related protein (AGRP), whereas expression of melanin concentrating hormone (MCH) is unaffected by the transgene. We postulate that the partial correction of the obese/diabetes phenotype is due to the restoration of leptin sensitivity to POMC and AGRP/NPY hypothalamic neurons. We also postulate that the residual obesity and insulin resistance of NSE-Rb db 3J /db 3J mice may be due to the persistent abnormal activity of hypothalamic NPY/AGRP and MCH neurons. Furthermore, expression of NSE-Rb in animals lacking only LEPR-B (db/db mice) results in body weights similar to those seen in NSE-Rb db 3J /db 3J mice, suggesting that short LEPR isoforms play a limited role in body weight regulation. These experiments indicate the feasibility of using molecular genetic tools to dissect the roles of specific neuronal populations in energy balance, body weight regulation, and appetitive behavior.
RESEARCH DESIGN AND METHODS
Transgene construction. The full-length cDNA encoding mouse LEPR-B was obtained from D. White (Millennium Pharmaceuticals) in the pMET7 expression vector (14) . The SR-␣ promoter of the pMET7 vector was excised and replaced with a synthetic polylinker containing restriction sites for PacI, PmeI, and AscI. A 1.8 kb SacI/XhoI fragment containing the NSE (Eno2) promoter/enhancer (27) (gift from Dr. G. Sutcliffe) was inserted into the PacI site. A rat growth hormone intron (generated by polymerase chain reaction [PCR]) was inserted into the AscI site between the NSE promoter/enhancer and the LEPR-B cDNA (Fig. 1) to enhance transcription of the LEPR-B transgene (28, 29) . A simian virus 40 (SV40) late polyadenylation signal, present in the pMET7 vector, was 3Ј of the LEPR-B cDNA. The transgene construct was excised using HindIII and SacI and purified from the vector by velocity sedimentation in a linear 5-25% sodium chloride gradient. Fractions containing the construct were pooled and dialyzed against TE (1 mmol/l Tris, pH 8.0, 0.1 mmol/l EDTA). Production of transgenic mice. DNA was microinjected into fertilized C57BL/6JϫCBA F2 oocytes. Surviving oocytes were transferred to the oviducts of pseudopregnant foster mothers according to previously described methods (30) . These procedures were performed by the Herbert Irving Comprehensive Cancer Center Transgenic Mouse Facility at Columbia University. Sixteen progeny were obtained, two of which were positive for the transgene by PCR analysis of ear-clip DNA (see below; male #3 and male #12). The two male founders were mated with C57BL/6J.129-A wJ db 3J congenic females (see below). Both males transmitted the transgene to their progeny. The expression of the transgene was evaluated in progeny by reverse transcription (RT)-PCR analysis using two primer pairs: the 5Ј end was amplified using primers based on sequences after the NSE transcription start site and a sequence specific to LEPR-B, and the 3Ј end was amplified using primers based upon the SV40 polyA sequence and a LEPR-B-specific sequence. The progeny of male #3 expressed full-length LEPR-B mRNA. The progeny of male #12, however, expressed a truncated LEPR-B mRNA consisting only of the 3Ј end. Thus, only line #3 was used for further analysis and line #12 was discontinued.
Line #3 progeny were backcrossed to C57BL/6J.129-A wJ /A wJ db 3J /+ congenics to generate N3E and N4E (N3 and N4 equivalent, respectively) experimental animals. The B6 congenic line used (N10F4 or N10F5 C57BL/6J.129-A wJ db 3J mice) carrying the db 3J mutation was developed by this laboratory from 129/J-db 3J animals provided by Dr. Ed Leiter (Jackson Labs). The db 3J mutation was crossed onto white-bellied agouti C57BL/6J-A wJ mice (co-isogenic with C57BL/6J) to enable easy visual discrimination from black C57BL/6J mice harboring the db mutation (see below). To generate NSE-Rb db/db animals, transgenic progeny of initial matings (line #3) were initially crossed with FVB.C57BLKS/J-db congenic females (congenic FVB.BLKS-db animals were generated by this laboratory and were used in initial matings to increase the number of transgenic progeny). Progeny from this mating were backcrossed to C57BL/6J-m db congenic mice to generate N1 and N2 experimental animals. The B6 congenic line used (N10F4 or N10F5 C57BL/6J-m db mice) carrying the db mutation was developed by this lab using N8 C57BL/6J-m db/+ + breeders obtained from Jackson Labs. This is the stock in which the misty and diabetes mutations are maintained in the same phase. However, as our breeding progressed, we have observed numerous examples of recombination between misty and diabetes, i.e., obese animals that were not misty. Therefore, we have not specified the genotype at the misty locus for the experimental animals.
All animals used were maintained under barrier condition at 22°C with a 12h:12h light-dark cycle (0700-1900). Animals had free access to rodent food (Picolab Mouse Diet 20: 55% carbohydrate, 20% protein, 9% fat; PMI Nutrition International) and water unless specified. Pathogen testing is done on a quarterly basis, and all serologies have been negative to date. Preparation and analysis of genomic DNA. Transgenic mice were identified using PCR analysis of genomic DNA isolated from ear clips or tail clips. Tissue was digested in a buffer of 1% SDS, 1 mmol/l EDTA, 10 mmol/l Tris, pH 8.0 with 100 µg/ml proteinase K at 65°C overnight, followed by phenol/chloroform extraction and DNA precipitation. Amplification with primers NSE-Ex1B (5Ј-CCACCGGCTGAGTCTGCAGT-3Ј) and rGHINT-R (5Ј-TTGGCGCGCCGAGAGT CTAGAAAGAGAGACA-3Ј) produced a 242-bp fragment if the transgene is present and no product if the transgene is absent. The genotype at Lepr was determined by PCR analysis of ear-clip DNA as follows: the 17-bp deletion of the Lepr db3J mutation was identified using the following primers:
The Lepr db mutation was identified by an RsaI restriction site introduced by the mutagenic primer db-F1 and db-R (31):
Semiquantitative RT-PCR for LEPR and neuropeptide transcripts. Total RNA was isolated from tissues extracted with guanidinium salts (32) . Two micrograms of total RNA was reverse transcribed using MMLV Reverse Transcriptase (Life Technologies) and an anchored oligo-dT primer adaptor (Not-PA, Promega) as described by the manufacturer. Expression of the NSE-Rb transgene was evaluated using a nested PCR strategy. Two microliters of cDNA (20 ng equivalents of total RNA) was amplified with primers mObr-25 (5Ј-GATTTCACCACAACTTTCATTCTC-3Ј) and Not-PA using the following conditions: 94°C, 30 s; 55°C, 30 s; 72°C, 30 s for 20 cycles. One microliter of this PCR reaction was amplified with primers Lepr-Rb1 (5Ј-CCTGTTCCACG CACAGTCAC-3Ј) and Not-PA using the same PCR conditions as above for 35 cycles. A 255-bp fragment was generated if the NSE-Rb transcript was present. This protocol, however, did not amplify the endogenous LEPR-B transcript. The integrity of cDNA was examined by PCR amplification using a primer complementary to actin (5Ј-CTGGAGAAGAGCTATGAGCTGCCT-3Ј) and Not-PA, generating a 510-bp fragment (␤-actin) and a 691-bp fragment (␣ sk -actin).
One to two micrograms of hypothalamic RNA was reverse transcribed with Superscript II (Life Technologies) with 200 ng of the Not primer-adaptor and 0.5 mmol/l dNTPs in a total volume of 20 µl. After incubation at 45°C for 60 min, the samples were diluted to 200 µl with sterile water and incubated at 65°C for 20 min to inactivate the reverse transcriptase. All samples being compared were reverse transcribed simultaneously to minimize differences in the efficiency of cDNA synthesis. To minimize variation due to sample handling, all samples to be compared were amplified on the same thermal cycler, and all amplification products for a given pair of primers were electrophoresed on the same gel. The cycling parameters for three neuropeptide cDNAs (AGRP-32 cycles, NPY-30 cycles, and POMC-32 cycles) were 94°-60°-72°C for 30 s at each temperature plateau, whereas MCH cDNA was amplified for 26 cycles with an annealing temperature of 55°C. The optimal cycle number was determined from the db 3J /+ cDNA pool to place the linear range of amplification for 20-fold dilutions of the cDNA samples. All of the primer pairs are designed to span at least one intron to distinguish between amplification products derived from genomic DNA and cDNA. All primer pairs were empirically shown not to amplify any products from genomic DNA using the specified conditions. Primers were based on mouse and rat cDNA sequences: ␤-actin (33), AGRP (34), MCH (33), NPY (GenBank Accession # AF273768), and POMC (35) . The rat MCH sequence was aligned to two mouse MCH-like expressed sequence tags for optimal homology to mouse MCH mRNA.
For quantitative analysis of LEPR-B transcripts, serial twofold dilutions (6 for db 3J /+ and db 3J /db 3J and 12 dilutions for NSE-Rb db 3J /db 3J ) were amplified in duplicate with LEPR-B and actin primers. For quantitation of neuropeptide cDNAs, the samples were diluted 1:20 with water, and 5 µl of the diluted samples was used for amplification in duplicate in 25 µl reactions. A standard curve was generated from serial twofold dilutions (8-10 dilutions in duplicate) of a pool of the cDNA samples from db 3J /+ animals. The procedure has been previously described (23) . The amplified products were size fractionated on an agarose gel (2% agarose + 1% low-melting-temperature agarose) containing ethidium bromide. DNA-bound fluorescence was quantified with an 8-bit video camera using QuantOne software (BioRad). The amount of amplified product is determined by the following equation:
where T 0 is the initial amount of template, j is the number of PCR cycles, E t is the mean efficiency of amplification per cycle, and T j is the amount of product after j cycles (36) . Taking the logarithm of Eq. 1, we obtain:
Because Eq. 2 applies within the linear range of amplification, a plot of log T 0 to log T j should yield a straight line. Samples with equivalent amounts of the template mRNA will yield superimposable lines with similar slopes and intercepts. Samples with varying amounts of the template mRNA will yield parallel lines with identical slopes (identical amplification efficiencies) but different intercepts (varying T 0 ). Although this procedure does not provide absolute quantification, relative differences in the fractional contents of a given mRNA species between various samples can be inferred by calculations that solve for T 0 at equivalent T j for different samples. The inclusion of a standard housekeeping gene as an internal standard provides data equivalent to highthroughput real-time RT-PCR methods (37, 38) . Measurement of blood glucose, leptin, and insulin. Tail blood for glucose, insulin, and leptin measurements was collected from fed and/or 24-h fasted animals between 0800 and 1200 while they were lightly restrained. Glucose was measured using the glucose-oxidase method (Glucometer Elite; Bayer, Elkhart, IN). Serum insulin was quantified using a commercial radioimmunoassay kit with rat insulin as standard (Linco, St. Louis, MO). Serum leptin was quantified using a commercial enzyme-linked immunosorbent assay kit (Crystal Chem, Chicago). Measurement of fat pad weights and BMI. Animals were killed by CO 2 asphyxiation and bled by cardiac puncture for measurement of leptin and insulin. The naso-anal length (NAL) was measured and the BMI calculated as the body weight/NAL 2 (g/cm 2 ). The right inguinal, retroperitoneal, and perigonadal depots and the mesenteric depot were dissected and weighed. The total adipose depot weight of each animal was defined as the sum of ([right inguinal, retroperitoneal, and perigonadal depots] ϫ 2) + (mesenteric depot). Glucose tolerance test. Tail blood was collected from 15-to 20-week-old mice before and after 24 h of food deprivation for measurement of whole blood glucose concentrations. After 24-h food deprivation, glucose (1 mg/g 0.75 ) was administered intraperitoneally, and tail blood (5 µl) was collected for glucose measurements (while mice were lightly restrained) before and 20, 40, 60, and 90 min after glucose administration. Doses were calculated to a power function of body weight to accurately reflect metabolic mass. Cold tolerance test. Core (rectal) temperature of individually housed mice was measured using a thermocouple probe (IT-18, Physitemp) connected to a thermocouple thermometer (BAT-10, Physitemp) at 22°C ambient and at 0.5, 1, 1.5, and 2 h after being placed at 4°C ambient. Mice were manually restrained during probe insertion. Measure of food intake. Daily pelleted mouse chow (Picolab Rodent Chow 5058) intake of individually housed mice was calculated from 24-h, 48-h, or 72-h intake measures. Food intake was expressed as g chow/day and g chow · (g body wt)
-0.75 · day -1 . Statistical analysis. All values are expressed as means ± SE, unless otherwise indicated. Statistical differences among genotypes were assessed by a KruskalWallis H-test followed by a Mann-Whitney U test where appropriate. A paired Student's t test was used to assess statistical differences between fed and fasted states. A one-tailed test with a P value <0.05 was considered significant.
RESULTS
Transgene construction and generation of NSE-Rb transgenic mice. The NSE-Rb construct (Fig. 1) places the LEPR-B cDNA under the control of the NSE (Eno2) promoter (27) . A rat growth hormone intron was placed between the promoter and the cDNA to enhance expression of the transgene. Of two transgenic lines produced by the oocyte injections, one line was found to contain the full NSERb transgene. This line was used in all subsequent experiments. The second line was lacking the NSE promoter by PCR analysis of genomic DNA and was discontinued.
Nested RT-PCR analysis showed that, as expected, the transgene is expressed in all brain regions examined (hypo-thalamus, cortex, hindbrain, and cerebellum) ( Fig. 2A and B) . Low levels of NSE-Rb expression were seen in adrenals, white adipose tissue, and testis. Of note, there was no detectable LEPR-B mRNA from the transgene in the pancreas or in brown adipose tissue. /+) higher concentrations in the hypothalamus than is the endogenous Lepr gene (Fig. 2C) . The large differences in transcript concentrations derived from the transgene and the endogenous gene account for the failure to amplify a fragment from the endogenous gene using the nested PCR approach that used an anchored oligo-dT downstream primer. We were unable to amplify any fragments that contained the 17-bp deletion of the db 3J mutation from db The NSE-Rb transgene was backcrossed three times (N4 equivalents, ~93% C57BL/6J) to two Lepr db congenic lines, C57BL/6J -A wJ /db 3J and C57BL/6J -m db, to generate a more uniform genomic composition and to allow direct comparisons to published literature using the C57BL/6J strain. The db 3J mutation is maintained on the co-isogenic B6-A wJ line to allow visual discrimination between the two congenic lines (the B6-m db line produces black mice whereas the B6-A wJ /db 3J line produces white-bellied agouti mice). All experimental animals were typed for the presence/absence of the transgene, which was maintained in the hemizygous state. All matings were between a transgenic mouse and a nontransgenic mate. The NSE-Rb transgene partially corrects the obesity and hyperphagia of db 3J /db 3J mice. The NSE-Rb transgene significantly ameliorated the obesity of db 3J /db 3J mice, as evidenced by somatic growth curves (Fig. 3A and B) (data not shown). Thus, the transgene failed to restore the deficit in fasting-mediated regulation of plasma leptin seen in db 3J /db 3J mice. The lower body weight and total fat pad mass of NSE-Rb db 3J /db 3J mice was associated with lower daily food intake ( Table 3 ). The 24-h food intake of 11-to 12-week-old NSE-Rb db 3J /db 3J mice was not significantly different from the intake of db 3J /+ mice, although there was a trend toward a higher intake in male NSE-Rb db 3J /db 3J mice (P = 0.08). No significant differences among groups were observed when food intake was expressed as a power function of body weight (body weight 0.75 ), which is proportional to metabolic mass. The NSE-Rb transgene corrects the cold intolerance of db 3J /db 3J mice. Mice that lack leptin or LEPR are hypothermic and have a reduced thermogenic response to cold challenge, due primarily to decreased sympathetic stimulation of brown adipose tissue (40) . When 16-to 20-week-old male db 3J /db 3J mice were placed at 4°C, there was a significant 7.4 ± 1.7°C decrease in their core temperature by 1 h as measured with a rectal probe (Fig. 4A) /db 3J male mice maintained their core temperature during 2 h at 4°C, with no significant difference from the basal core temperature in either genotype at any time point.
The correction of the thermogenic defect by the transgene is attenuated in females (Fig. 4B) (Table 2 ). There was, however, only a partial correction of the hyperinsulinemia. It is possible that the hyperinsulinemia in NSE-Rb db 3J /db 3J mice is due to their persistent excess adiposity. The glucose tolerance curves of male NSE-Rb db 3J /db 3J and lean mice were similar (Fig. 5A) /+ or +/+ mice, indicating a persistent but attenuated glucose intolerance (Fig. 5B) . Effects of NSE-Rb on expression of hypothalamic POMC, NPY, AGRP, and MCH. To specify the neuronal substrates that mediate the various effects of the NSE-Rb transgene, we performed quantitative analysis (by semiquantitative RT-PCR and in situ hybridization) of the hypothalamic expression of four neuropeptide genes (Fig. 6 ) that are regulated by leptin and abnormally expressed in LEPRdeficient rodents: POMC, AGRP, NPY, and MCH. POMC transcripts (Fig. 6A) /db 3J genotypes, the observation of a significant increase of POMC mRNA in the transgenic females indicates the bestowal of leptin sensitivity of POMC neurons by the NSERb transgene in both male and female db 3J /db 3J mice. Leptinreceptor deficiency increased Agrp expression (Fig. 6C) , whereas AGRP transcripts were reduced by the transgene but not normalized to the amounts observed in db 3J /+ animals in both male and female NSE-Rb db 3J /db 3J mice. We also found a reduction, but not full normalization, of NPY mRNA (Fig. 6B ) in male db 3J /db 3J mice due to the transgene by in situ hybridization, although we were unable to observe a transgene effect by RT-PCR analysis (data not shown). Contrary to the NSE-Rb transgene's effects on arcuate nucleus neurons, there was no difference in MCH mRNA (Fig. 6D) /+ mice of both sexes had significantly lower MCH mRNA concentrations than the db 3J mutant mice (transgenic and nontransgenic). Therefore, the partial corrections in the obesity/diabetes phenotype that are observed in the NSE-Rb db 3J /db 3J mouse may be due to the restoration of leptin sensitivity to arcuate nucleus neurons expressing POMC/cocaine-and amphetamine-regulated transcript (CART) and AGRP/NPY, whereas the residual deficiencies could be due to dysregulation of MCH neurons in the lateral hypothalamus and some AGRP/NPY neurons in the arcuate nucleus. 
Rb transgene to correct completely the obesity in LEPR-null (db
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/db 3J ) mice is due to the absence of other LEPR isoforms (e.g., LEPR-Ra, Rc, Rd, or Re). To explore this possibility, we evaluated the effect of the NSE-Rb transgene on the obesity of db/db mice that are deficient in only the B isoform of LEPR. Similar to observations in db 3J /db 3J mice, the presence of the NSE-Rb transgene did not fully correct the obesity phenotype of 16-to 18-week-old male db/db mice. The body weights of db/db (n = 5), NSE-Rb db/db (n = 4), and db/+ or +/+ (n = 3) mice were 70 ± 2, 53 ± 1, and 43 ± 2 g, respectively, and the adipose depot masses were 13 ± 0.5, 6.7 ± 0.6, and 5.8 ± 0.1 g, respectively. Because NSE-Rb db/db mice possess the full complement of short LEPR isoforms, the lack of a full correction of obesity in NSE-Rb db 3J /db 3J mice cannot be explained by the absence of these short LEPR isoforms. The possibility that the short isoforms may subtly modify the phenotype of NSE-Rb db/db animals relative to NSE-Rb db 3J /db 3J animals cannot, however, be excluded. ) has a significant effect on body weight, glucose homeostasis, thermoregulatory thermogenesis, and reproduction, and that coexpression of the short isoforms of LEPR (NSE-Rb db/db mice) does not appear to modify this response.
The control of feeding behavior and energy expenditure by circulating leptin appears to be mediated primarily by LEPR-B signaling within the hypothalamus. The demonstrations that LEPR-B expression is highest in the hypothalamus (19) , that peripheral and central leptin injections produce similar effects on feeding and energy expenditure in Lep-null mice (7) (8) (9) , that db/db mice and Lepr-null mice have an apparently identical obesity/diabetes phenotype (1), and that peripheral leptin injection activates STAT3 in hypothalamic neurons but not in peripheral tissue (41) are consistent with this view. Within the hypothalamus, leptin seems to act by modulating the expression, release, and actions of several orexigenic and anorexigenic neuropeptides (42) .
The NSE-Rb db
/db 3J transgenic mice express the LEPR-B mRNA at high levels throughout the brain and at much lower levels in adrenals, testis, and white adipose tissue. The NSE-Rb db/db transgenic mice have the same pattern of LEPR-B expression but possess the full complement of short LEPR isoforms in all tissues. The demonstration that the body weights of the NSE-Rb db 3J /db 3J and NSE-Rb db/db mice are similar suggests that the shorter LEPR isoforms are of limited importance in body weight regulation. The failure to achieve a full correction of the obesity phenotype of Lepr-null mice may be attributed to one or more of the following potential factors: 1) absence of the LEPR-B transgene in critical hypothalamic neurons due to mosaic expression; 2) failure of the transgene to enable production of the appropriate number of leptin receptors in relevant neurons; and 3) absence of LEPR-B transgene expression in critical peripheral tissue(s). Both CNS and direct peripheral actions of leptin have been proposed to mediate the hormone's effects on glucose homeostasis. Because the NSE-Rb transgene is not expressed in the pancreas or in skeletal muscle, the effects of circulating leptin on glucose metabolism in NSE-Rb db 3J /db 3J mice must be mediated by LEPR-B-mediated signaling events in the CNS or white adipose tissue. Although the endogenous NSE gene (Eno2) is expressed in all peripheral and central neurons, the DNA fragment used in constructing the NSE-Rb transgene does not fully replicate the pattern of expression of the natural Eno2 gene. Moreover, integration site effects have important consequences for transgene expression, emphasizing the necessity of characterizing each transgene integration site independently. The increased skeletal muscle glucose uptake in response to intracerebroventricular leptin administration suggests that leptin's effects on skeletal muscle are mediated primarily through the CNS (43) . Although direct actions of leptin on adipocytes are possible, it is likely that circulating leptin affects the adipose tissue glucose metabolism of NSE-Rb db 3J /db 3J mice via CNS-related mechanisms, because the transgene reduces the ratio of circulating leptin to fat pad mass ( (Fig. 2) , the restoration of cold tolerance in these mice indicates that reported direct effects of leptin on glucose and lipid metabolism in brown adipose tissue in vitro (47) can be replaced by sympathetic activation mediated by leptinresponsive neurons. Similarly, sympathetic activation with a sympathetic agonist or a cold environment can circumvent the thermogenic defect of leptin deficiency (50, 51 /db 3J mice is due to expression of the NSE-Rb transgene in testis (Fig. 2) . Recent work, however, demonstrates that plasma leptin enters the testes in a nonsaturable manner and that LEPR is not expressed in Leydig or Sertoli cells (52) , which raises questions regarding the relevance of LEPR as a transporter or as a signaling mechanism in this tissue and suggests that the effect of the NSE-Rb transgene on fertility in male LEPR-null mice is due to the restoration of The failure of the transgene to restore fertility in female LEPR-null mice may be due to the persistent adiposity seen in these mice or to the failure to correct completely the defects in the hypothalamic-pituitarygonadal axis, and not to a requirement for LEPR-B signaling in ovarian tissue. These inferences are supported by the facts that ovaries transplanted from db/db mice to +/+ mice function normally (53) and that mice made obese by high-fat feeding fail to cycle normally (54) . Additionally, preliminary data show that NSE-Rb db/db female mice are not fertile whereas NSE-Rb db/db males are, indicating that the lack of short LEPR isoforms in the ovaries of NSE-Rb db 3J /db 3J mice is not responsible for the failure to restore fertility. The sex differences that the NSE-Rb transgene produces are intriguing. Although we have shown that the transgene did not integrate into the X chromosome (male hemizygotes produce male and female transgenic progeny), it is possible that the transgene integrated at a site that confers sex-specific modulation of transgene expression. There were no data that indicated that the NSE promoter has sex-specific effects on transgene expression.
The quantitative analysis of neuropeptide gene expression in the hypothalamus suggests a critical role for POMC and AGRP/NPY (55) arcuate nucleus neurons in the obesity/diabetes syndrome of leptin-receptor deficiency (42) . Although these are the neuropeptide genes whose transcript concentrations were measured, it is likely that the entire set of neurotransmitter activities of these two neuronal populations is affected by the NSE-Rb transgene, such as CART in POMC neurons (56) (57) (58) , because leptin hyperpolarizes neurons (59), thereby inhibiting neuronal activity and synaptic transmission. It is remarkable that several aspects of LEPR deficiency, such as glucose tolerance and fertility in males, can be corrected by near-normalization of leptin sensitivity in POMC and AGRP/NPY neurons. It should be noted that NPY deficiency does not correct glucose intolerance in leptin-deficient mice (60) , whereas overexpression of Agouti (61) and AGRP (34) does not produce overt diabetes, suggesting that the activity of hypothalamic POMC neurons is important to the maintenance of normoglycemia. In support of this supposition is the observation that mice lacking the melanocortin receptor 4 (MC4R)-the receptor for ␣-melanocyte stimulating hormone (a peptide processed from the POMC preprotein) and AGRP-develop hyperglycemia and are also infertile (62) . However, an intact hypothalamus is necessary for the development of hyperglycemia in LEPR-deficient rodents (in diabetes-susceptible strains) because ventromedial hypothalamic lesions, either chemically or electrolytically induced, prevent the development of diabetes without affecting the degree of obesity (63) . Ventromedial hypothalamic lesions also ablate the arcuate nucleus, removing both POMC and AGRP/NPY neuronal populations. Because we have not controlled for adiposity between transgenic and nontransgenic LEPR-deficient mice in our study, it remains a formal possibility that the diminished adiposity in NSE-Rb mice may be sufficient to account for improved glycemic control. Based on a comparative survey of the current literature cited previously, we believe that it is likely that the combined actions of at least two neuronal populations in the arcuate nucleus, including POMC neurons and AGRP/NPY neurons, are important for regulating glucose homeostasis.
The persistent adiposity, insulin resistance, and female infertility of NSE-Rb LEPR-deficient mice may be ascribed to the partial (for AGRP/NPY neurons) or complete (for MCH neurons) leptin insensitivity of a subset of hypothalamic neurons. The lack of fasting-induced suppression of circulating leptin by the NSE-Rb transgene suggests that LEPR may be a potential regulator of leptin secretion. Although our data are compatible with the possibility of peripheral actions of leptin/leptin receptor contributing to the obesity/diabetes syndrome, a direct test of this hypothesis is required by evaluation of the phenotype of mice expressing LEPR-B in adipocytes only. In addition, we are performing further studies where higher levels of LEPR-B transgene expression, i.e., in the homozygous state, may affect adiposity in lean and genetically obese mice.
In summary, we have demonstrated that expression of LEPR-B predominantly in the brain of mice otherwise null for all LEPR isoforms affects all fundamental aspects of the obesity/diabetes syndrome, as the NSE-Rb transgene partially rescues the obesity/diabetes phenotype, restores fertility in male animals, and fully corrects the impaired thermoregulatory thermogenesis in males. Future experiments in transgenic mice in which expression of LEPR-B is restricted to specific hypothalamic neurons (e.g., POMC-or AGRP/NPY-expressing neurons) or peripheral tissues (e.g., adipose tissue) will help to define the minimum molecular and neuronal phenotypes required for mediation of leptin's behavioral and metabolic effects.
